Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 1.92M | $18.0M | 8.45% | -- | 2026-06-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.52M | $14.0M | 6.71% | -285.0K | 2026-06-30 |
| ACORN CAPITAL ADVISORS, LLC | 1.52M | $14.0M | 6.69% | +1.23M | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 1.42M | $13.0M | 6.28% | +477.1K | 2026-06-30 |
| BlackRock, Inc. | 1.42M | $13.0M | 6.26% | +1.17M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 959.0K | $9.0M | 4.23% | +219.2K | 2026-06-30 |
| Catalio Capital Management, LP | 940.9K | $9.0M | 4.15% | +43.1K | 2026-06-30 |
| Avidity Partners Management LP | 924.5K | $9.0M | 4.08% | +460.7K | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 786.3K | $7.0M | 3.47% | -755.8K | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 695.3K | $6.0M | 3.07% | -- | 2026-06-30 |
